August 2021 FDA Recall Oxycodone Hydrochloride by Rhodes Pharmaceuticals, L.p.
D-0794-2021 - Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle

This Class II drug recall was voluntarily initiated by Rhodes Pharmaceuticals, L.p. on August 19, 2021 for the product Oxycodone Hydrochloride. The FDA reported the reason for recall as presence of foreign tablets/capsules; a single foreign tablet hydrochlorothiazide/lisinopril 25/20 was found in one bottle. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0794-2021

Reason for Recall
Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle
Initiated
08-19-2021
Reported
09-22-2021
Quantity
55,344/100 count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Rhodes Pharmaceuticals, L.P.
Product was distributed nationwide.
Oxycodone Hydrochloride Tablets, USP, 10 mg, 100 count bottle, Rx only, Marketed by: Rhodes Pharmaceuticals L.P., Coventry RI 02816, Manufactured by: Purdue Pharma L.P., Stanford, CT 06901 NDC 42858-002-01

Batch or Lot Expiration Information

Lot# WP5K0Y, exp. date 02/28/2023